Publication:
Effect of different storage solutions on oxidative stress in human saphenous vein grafts

dc.contributor.authorTekin, Ilker
dc.contributor.authorDemir, Meltem
dc.contributor.authorÖzdem, Sebahat Nacitarhan
dc.contributor.institutionTekin, Ilker, Department of Cardiovascular Surgery, Manavgat Government Hospital, Manavgat, Turkey, Department of Cardiovascular Surgery, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.contributor.institutionDemir, Meltem, Department of Biochemistry, Medicalpark Hospital, Antalya, Turkey, Faculty of Health Sciences, Demiroglu Bilim University, Istanbul, Turkey
dc.contributor.institutionÖzdem, Sebahat Nacitarhan, Department of Medical Biochemistry, Akdeniz University, Faculty of Medicine, Antalya, Turkey
dc.date.accessioned2025-10-05T15:12:20Z
dc.date.issued2022
dc.description.abstractBackground: Ischemia–reperfusion injury of saphenous vein grafts (SVG) during coronary artery bypass grafting surgery negatively impacts endothelial integrity and functionality and is associated with vein graft failure. The aim of this study was to evaluate the level of oxidative stress in human SVG segments following ischemic storage in three intraoperative graft storage solutions: saline (S), autologous heparinized blood (HB) and DuraGraft (DG). Methods: 3 mm tissue rings derived from surplus SVG segments from 50 patients were stored at room temperature for 30 min in DG, S or HB. Total oxidative status (TOS) and total antioxidant status (TAS) levels were determined from which the oxidative stress index (OSI: TOS/TAS ratio) was calculated. A p-value < 0.017 was considered significant implementing a Bonferroni correction. Results: TOS values were significantly lower for DG stored samples in comparison to both S and HB, there was no difference between S and HB (DG: 32.6 ± 1.8, S: 39.6 ± 2.8 and HB: 40.6 ± 2.4 µmol H<inf>2</inf>O<inf>2</inf> eqv., DG vs. S and DG vs. HB p < 0.0001, S vs. HB p = 0.047). TAS was higher for both DG and HB in comparison to S (DG: 8.9 ± 0.9, S: 6.9 ± 1.0 and HB: 8.6 ± 0.9 mmol Trolox eqv., DG vs S p < 0.0001, DG vs. HB p = 0.263, S vs. HB p < 0.0001). OSI differed between all groups with the lowest value for DG (DG: 3.7 ± 0.2, S: 5.8 ± 0.4 and HB: 4.7 ± 0.2 µmol H<inf>2</inf>O<inf>2</inf> eqv./mmol Trolox eqv., all p < 0.0001). Conclusions: Saphenous veins grafts stored in DuraGraft had a lower oxidative level, higher antioxidant level and a lower oxidative stress index in comparison to saphenous vein grafts stored in saline or heparinized blood. ClinicalTrials.gov Identifier NCT02922088. © 2022 Elsevier B.V., All rights reserved.
dc.identifier.doi10.1186/s13019-022-01752-7
dc.identifier.issn17498090
dc.identifier.issue1
dc.identifier.pubmed35034655
dc.identifier.scopus2-s2.0-85122923909
dc.identifier.urihttps://doi.org/10.1186/s13019-022-01752-7
dc.identifier.urihttps://hdl.handle.net/20.500.14719/8499
dc.identifier.volume17
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.oastatusAll Open Access
dc.relation.oastatusGold Open Access
dc.relation.oastatusGreen Accepted Open Access
dc.relation.oastatusGreen Final Open Access
dc.relation.oastatusGreen Open Access
dc.relation.sourceJournal of Cardiothoracic Surgery
dc.subject.authorkeywordsCoronary Artery Bypass Graft
dc.subject.authorkeywordsEndothelial Damage Inhibitor
dc.subject.authorkeywordsStorage Solution
dc.subject.authorkeywordsVein Graft Failure
dc.subject.authorkeywordsHydrogen Peroxide
dc.subject.authorkeywordsHydrogen Peroxide
dc.subject.authorkeywordsHydrogen Peroxide
dc.subject.authorkeywordsCoronary Artery Bypass Graft
dc.subject.authorkeywordsHuman
dc.subject.authorkeywordsOxidative Stress
dc.subject.authorkeywordsSaphenous Vein
dc.subject.authorkeywordsCoronary Artery Bypass
dc.subject.authorkeywordsHumans
dc.subject.authorkeywordsHydrogen Peroxide
dc.subject.authorkeywordsOxidative Stress
dc.subject.authorkeywordsSaphenous Vein
dc.subject.indexkeywordshydrogen peroxide
dc.subject.indexkeywordscoronary artery bypass graft
dc.subject.indexkeywordshuman
dc.subject.indexkeywordsoxidative stress
dc.subject.indexkeywordssaphenous vein
dc.subject.indexkeywordsCoronary Artery Bypass
dc.subject.indexkeywordsHumans
dc.subject.indexkeywordsHydrogen Peroxide
dc.subject.indexkeywordsOxidative Stress
dc.subject.indexkeywordsSaphenous Vein
dc.titleEffect of different storage solutions on oxidative stress in human saphenous vein grafts
dc.typeArticle
dcterms.referencesSousa-Uva, Miguel, 2018 ESC/EACTS Guidelines on myocardial revascularization, European Journal of Cardio-thoracic Surgery, 55, 1, pp. 4-90, (2019), Caliskan, Etem Ibrahim, Saphenous vein grafts in contemporary coronary artery bypass graft surgery, Nature Reviews Cardiology, 17, 3, pp. 155-169, (2020), Halabi, Abdul R., Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery, American Journal of Cardiology, 96, 9, pp. 1254-1259, (2005), Yau, James M., Impact of Perioperative Myocardial Infarction on Angiographic and Clinical Outcomes Following Coronary Artery Bypass Grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV), American Journal of Cardiology, 102, 5, pp. 546-551, (2008), FitzGibbon, Gerald M.P., Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years, Journal of the American College of Cardiology, 28, 3, pp. 616-626, (1996), Deb, Saswata, Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: Results from RAPS (Radial Artery Patency Study), Journal of the American College of Cardiology, 60, 1, pp. 28-35, (2012), Shuhaiber, Jeffrey H., Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery, European Journal of Cardio-thoracic Surgery, 22, 3, pp. 387-396, (2002), Osgood, Michael J., Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein, Journal of Vascular Surgery, 60, 1, pp. 202-211, (2014), World J Transplant, (2015), Harskamp, Ralf Egan, Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: Follow-up from PREVENT IV randomized clinical trail, JAMA Surgery, 149, 8, pp. 798-805, (2014)
dspace.entity.typePublication
local.indexed.atScopus
person.identifier.scopus-author-id15844262400
person.identifier.scopus-author-id56689396100
person.identifier.scopus-author-id6701608054

Files